Methylprednisolone Acetate

Greenstone Llc has initiated a voluntary Class II nationwide recall (D-0299-2026) for 3,456 cartons of methylprednisolone tablets, USP Dosepak, 4 mg. The recall stems from an incorrect orientation of the blister foil, leading to erroneous dosing instructions. This packaging error, affecting Lot # LG7675, Exp. Date Nov 2026, poses a risk of incorrect medication administration, necessitating immediate action from procurement and regulatory teams to assess supply chain integrity and patient safety protocols.

Sagent Pharmaceuticals has initiated a nationwide Class II recall for 14,360 vials of Methylprednisolone Acetate Injectable Suspension due to black particulate matter. This voluntary action, affecting product manufactured in India, necessitates immediate supply chain and procurement review. Regulatory affairs must assess compliance, while business development monitors market shifts for this critical corticosteroid.

Eugia US LLC has initiated a Class II recall for Methylprednisolone Acetate Injectable Suspension due to failed dissolution specifications, impacting 10,080 vials distributed across OH, TN, LA, MS. This event highlights critical supply chain vulnerabilities for essential corticosteroids, necessitating immediate action from procurement and regulatory teams to assess exposure and identify qualified alternative suppliers to ensure continuity of patient care and market supply.